Stock PROTAGONIST THERAPEUTICS INC
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

MarketScreener Editorial Features Protagonist Therapeutics Inc Nasdaq

Equities

US74366E1029

End-of-day quote Nasdaq
Other stock markets
- PTS - Intraday chart for Protagonist Therapeutics Inc
05-07 Protagonist Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
04-03 Protagonist Therapeutics Insider Sold Shares Worth $707,750, According to a Recent SEC Filing MT

MarketScreener Editorial Features

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Today on Wall Street: It's just a period of market normalizationToday on Wall Street: It's just a period of market normalization October 12, 2021 at 02:16 pm
Analyst recommendations: Cigna, Halliburton, Nike, Nio, Trex...ANALYST RECOMMENDATIONS : Cigna, Halliburton, Nike, Nio, Trex... October 12, 2021 at 11:20 am
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. PTGX Stock
  4. Stock
  5. News Protagonist Therapeutics Inc
  6. MarketScreener Editorial Features